OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics
Alessandro Zorzi, Sara Linciano, Alessandro Angelini
MedChemComm (2019) Vol. 10, Iss. 7, pp. 1068-1081
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Alessandra Spada, Jaber Emami, Jack A. Tuszyński, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 5, pp. 1862-1894
Closed Access | Times Cited: 354

Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114726-114726
Open Access | Times Cited: 40

Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Mohammad Abdallah, Olivia Müllertz, Ian K. Styles, et al.
Journal of Controlled Release (2020) Vol. 327, pp. 117-128
Open Access | Times Cited: 79

Serum albumin: clinical significance of drug binding and development as drug delivery vehicle
Saad Tayyab, Shevin Rizal Feroz
Advances in protein chemistry and structural biology (2020), pp. 193-218
Closed Access | Times Cited: 71

Serum Albumin for Magnetic Nanoparticles Coating
Alexey S. Chubarov
Magnetochemistry (2022) Vol. 8, Iss. 2, pp. 13-13
Open Access | Times Cited: 50

Deciphering albumin-directed drug delivery by imaging
Huiyu Hu, Jeremy M. Quintana, Ralph Weissleder, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114237-114237
Open Access | Times Cited: 37

Diverse Roles of Antibodies in Antibody–Drug Conjugates
Aiko Yamaguchi, H. Charles Manning
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 180-180
Open Access

Spectrofluorimetric analysis of the binding of a target molecule to serum albumin: tricky aspects and tips
Francesca Macii, Tarita Biver
Journal of Inorganic Biochemistry (2020) Vol. 216, pp. 111305-111305
Open Access | Times Cited: 66

Albumin-based drug designs for pharmacokinetic modulation
Diego Pilati, Kenneth A. Howard
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 9, pp. 783-795
Closed Access | Times Cited: 59

Albumin: An Emerging Opportunity in Drug Delivery
Parastou Rahimizadeh, Sung‐Tae Yang, Sung In Lim
Biotechnology and Bioprocess Engineering (2020) Vol. 25, Iss. 6, pp. 985-995
Closed Access | Times Cited: 53

Protein Engineering Strategies for Improved Pharmacokinetics
Aurélie Rondon, Sohaib Mahri, Francisco Morales-Yánez, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 44
Open Access | Times Cited: 43

Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions
Sara Linciano, Giulia Moro, Alessandro Zorzi, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 115-126
Closed Access | Times Cited: 34

Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
Lingxin Meng, Jianyang Fang, Liang Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8245-8257
Closed Access | Times Cited: 31

Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds
Giulia Moro, Stefano Liberi, Filippo Vascon, et al.
Chemical Research in Toxicology (2022) Vol. 35, Iss. 11, pp. 2049-2058
Open Access | Times Cited: 27

Human serum albumin binders: A piggyback ride for long-acting therapeutics
Aziz Ullah, Goeun Shin, Sung In Lim
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103738-103738
Closed Access | Times Cited: 18

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials
Tsutomu Takeuchi, Yukihiro Chino, Masafumi Kawanishi, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 16

Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis
Yoshiya Tanaka
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 579-587
Open Access | Times Cited: 15

Quantitative cross-species comparison of serum albumin binding of per- and polyfluoroalkyl substances from five structural classes
Hannah M. Starnes, Thomas W. Jackson, Kylie D. Rock, et al.
Toxicological Sciences (2024) Vol. 199, Iss. 1, pp. 132-149
Open Access | Times Cited: 5

Injectables and Depots to Prolong Drug Action of Proteins and Peptides
Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 999-999
Open Access | Times Cited: 40

Recent advances in protein metalation: structural studies
Antonello Merlino
Chemical Communications (2021) Vol. 57, Iss. 11, pp. 1295-1307
Closed Access | Times Cited: 34

Carborane-containing amino acids and peptides: Synthesis, properties and applications
Dmitry А. Gruzdev, Галина Л. Левит, В. П. Краснов, et al.
Coordination Chemistry Reviews (2021) Vol. 433, pp. 213753-213753
Closed Access | Times Cited: 32

Aptamers used for molecular imaging and theranostics - recent developments
Lennart Bohrmann, Tobias Burghardt, Charles A. Haynes, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4010-4050
Open Access | Times Cited: 25

Impact of conjugation to different lipids on the lymphatic uptake and biodistribution of brush PEG polymers
Mohammad Abdallah, Lihuan Lin, Ian K. Styles, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 146-162
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top